Dose-ranging Study in Patients With Type 1 Diabetes Mellitus

NCT02459899 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

141

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: Placebo
DRUG: Sotagliflozin

Sponsor

Lexicon Pharmaceuticals

Collaborators

[object Object]